Matti Annala

Aktiviteetit

Aktiviteetteja vuodessa 2010 2010 2013 2014 2015 2016 2017 2018

• 17 Konferenssiesitelmä
• 1 Kutsuttu esitelmä

Aktiviteetteja vuodessa

Hakutulokset

• A DREAM5 best performing method for TF binding affinity prediction in PBM microarrays

  Matti Annala (Keynote speaker)

  16 marrask. 2010

  Aktiviteetti: Kutsuttu esitelmä

• Best Performer (1st place) Main Challenge & Bonus Round

  Matti Annala (Speaker)

  2010

  Aktiviteetti: Konferenssiesitelmä

• Integrated Views into Cancer Regulomes Reveal Regulatory Hot Spots

  Matti Annala (Speaker)

  2011

  Aktiviteetti: Konferenssiesitelmä

• Novel prostate cancer specific transcripts identified using RNA-seq

  A Ylipää (Contributor), KK Waltering (Contributor), MJ Annala (Contributor), K Kartasalo (Contributor), L Latonen (Contributor), SP Leppänen (Contributor), M Scaravilli (Contributor), W Zhang (Contributor), T Visakorpi (Contributor) & M Nykter (Contributor)

  7 huhtik. 2013

  Aktiviteetti: Konferenssiesitelmä

• Integrative sequencing reveals alterations in untreated and castration resistant prostate cancer

  MJ Annala (Contributor), KK Waltering (Contributor), A Ylipää (Contributor), K Kartasalo (Contributor), K Tuppurainen (Contributor), L Latonen (Contributor), SP Leppänen (Contributor), S Karakurt (Contributor), O Saramäki (Contributor), M Scaravilli (Contributor), J Seppälä (Contributor), HE Rauhala (Contributor), O Yli-Harja (Contributor), RL Vessella (Contributor), TLJ Tammela (Contributor), W Zhang (Contributor), T Visakorpi (Contributor) & M Nykter (Contributor)

  6 huhtik. 2013

  Aktiviteetti: Konferenssiesitelmä

• SKIL fusions define a new ETS/SPINK1 negative prostate cancer subtype

  Kati Kivinummi (Contributor), Matti Annala (Contributor), Leena Latonen (Contributor), Matti Nykter (Contributor), Outi Saramäki (Contributor), Teuvo Tammela (Contributor) & Tapio Visakorpi (Contributor)

  17 syysk. 2014

  Aktiviteetti: Konferenssiesitelmä

• DOT1L-HES6 fusion drives androgen independent growth in prostate cancer

  Matti Annala (Contributor), Kati Kivinummi (Contributor), Matti Nykter (Contributor) & Tapio Visakorpi (Contributor)

  17 syysk. 2014

  Aktiviteetti: Konferenssiesitelmä

• Novel prostate cancer specific transcripts identified using RNA-seq

  Antti Ylipää (Contributor), Matti Annala (Contributor), Kati Kivinummi (Contributor), Leena Latonen (Contributor), Matti Nykter (Contributor), Mauro Scaravilli (Contributor), Teuvo Tammela (Contributor) & Tapio Visakorpi (Contributor)

  11 huhtik. 2014

  Aktiviteetti: Konferenssiesitelmä

• Transcriptome sequencing reveals PCAT5 - new ERG-regulated non-coding transcript in prostate cancer

  A Ylipää (Contributor), K Kivinummi (Contributor), M Annala (Contributor), A Kohvakka (Contributor), L Latonen (Contributor), M Scaravilli (Contributor), K Kartasalo (Contributor), SP Leppänen (Contributor), S Karakurt (Contributor), J Seppälä (Contributor), O Yli-Harja (Contributor), TLJ Tammela (Contributor), W Zhang (Contributor), T Visakorpi (Contributor) & M. Nykter (Contributor)

  18 huhtik. 2015

  Aktiviteetti: Konferenssiesitelmä

• Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer

  Matti Annala (Contributor), Kirsi Kaukoniemi (Contributor), Kati Kivinummi (Contributor), Leena Latonen (Contributor), Matti Nykter (Contributor), Outi Saramäki (Contributor) & Teuvo Tammela (Contributor)

  20 maalisk. 2015

  Aktiviteetti: Konferenssiesitelmä

• Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer

  M Annala (Contributor), K Kivinummi (Contributor), J Tuominen (Contributor), L Latonen (Contributor), A Ylipää (Contributor), O Rytövuor (Contributor), KM Kaukoniemi (Contributor), S Karakurt (Contributor), O Yli-Harja (Contributor), RL Vessella (Contributor), TLJ Tammela (Contributor), W Zhang (Contributor), T Visakorpi (Contributor) & M. Nykter (Contributor)

  20 maalisk. 2015

  Aktiviteetti: Konferenssiesitelmä

• Novel prostate cancer specific transcripts identified using RNA-seq

  Antti Ylipää (Contributor), Matti Annala (Contributor), Kati Kivinummi (Contributor), Leena Latonen (Contributor), Matti Nykter (Contributor), Mauro Scaravilli (Contributor), Teuvo Tammela (Contributor) & Tapio Visakorpi (Contributor)

  5 helmik. 2015

  Aktiviteetti: Konferenssiesitelmä

• Next generation sequencing panels to predict response to hormonal therapy in prostate cancer

  HML Kallio (Contributor), M Annala (Contributor), A Brofeldt (Contributor), R Hieta (Contributor), K Kivinummi (Contributor), T Tammela (Contributor), M Nykter (Contributor), HG Lilja (Contributor), S Bova (Contributor) & T Visakorpi (Contributor)

  15 syysk. 2016

  Aktiviteetti: Konferenssiesitelmä

• Expression of a novel androgen-regulated long noncoding RNA correlates with progression-free survival in prostate cancer patients

  Annika Kohvakka (Contributor), Matti Annala (Contributor), Kati Kivinummi (Contributor), Ville Kytölä (Contributor), Matti Nykter (Contributor) & Tapio Visakorpi (Contributor)

  15 syysk. 2016

  Aktiviteetti: Konferenssiesitelmä

• Integrative analysis of the proteome in primary and advanced prostate cancer

  Leena Latonen (Contributor), Ulla Aapola (Contributor), Afyounian Ebrahim (Contributor), Matti Annala (Contributor), Antti Jylhä (Contributor), Kati Kivinummi (Contributor), Matti Nykter (Contributor), Janika Nättinen (Contributor), Teuvo Tammela (Contributor), Hannu Uusitalo (Contributor) & Tapio Visakorpi (Contributor)

  2 jouluk. 2017

  Aktiviteetti: Konferenssiesitelmä

• Chromatin state alterations in human prostate cancer progression

  Joonas Tuominen (Contributor), Matti Annala (Contributor), Kirsi Granberg (Contributor), Tomi Häkkinen (Contributor), Kati Kivinummi (Contributor), Leena Latonen (Contributor), Matti Nykter (Contributor), Teuvo Tammela (Contributor) & Tapio Visakorpi (Contributor)

  2 jouluk. 2017

  Aktiviteetti: Konferenssiesitelmä

• Neoadjuvant hormonal therapies induce the expression of AR transcript variants

  T Tammela (Contributor), H Kallio (Contributor), M Annala (Contributor), A Brofeldt (Contributor), R Hieta (Contributor), K Kivinummi (Contributor), M Nykter (Contributor), H Lilja (Contributor), G Bova (Contributor) & T Visakorpi (Contributor)

  24 maalisk. 2017

  Aktiviteetti: Konferenssiesitelmä

• Integrative analysis of the proteome in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression

  Teuvo Tammela (Contributor), Ulla Aapola (Contributor), Afyounian Ebrahim (Contributor), Matti Annala (Contributor), Antti Jylhä (Contributor), Leena Latonen (Contributor), Matti Nykter (Contributor), Janika Nättinen (Contributor), Hannu Uusitalo (Contributor) & Tapio Visakorpi (Contributor)

  16 maalisk. 2018

  Aktiviteetti: Konferenssiesitelmä